Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
This study has suspended participant recruitment.
(Temporarily closed to accrual)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01238146
First received: November 9, 2010
Last updated: January 16, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |